UK SKIN CANCER PATIENTS FAST-TRACKED INTO VACCINE TRIAL

Mon 14 April 2025:

Patients with advanced skin cancer in England will be fast-tracked into a new cancer vaccine trial, the National Health Service (NHS) said Monday.

The NHS said in a statement that the needle-free injection, administered for up to two years, works by enhancing the immune system’s response – helping it recognize, attack and “remember” cancer cells to prevent the disease from returning.

“This kind of innovation is nothing short of life-saving and I want to see more of these world-leading treatments being developed in the UK,” Prime Minister Keir Starmer said.

The NHS partnered with UK life sciences company Scancell to expand access for patients nationwide.

The trial is part of NHS England’s Cancer Vaccine Launch Pad, described as “a world-first program” to fast-track eligible patients to cancer vaccine studies at their nearest participating hospital.

“The Launch Pad has already begun helping thousands of patients to access trials of a personalised vaccine against bowel cancer, with more than 350 patients fast-tracked for consideration, and has now expanded to include a trial for melanoma,” the statement said.

__________________________________________________________________________

https://whatsapp.com/channel/0029VaAtNxX8fewmiFmN7N22

__________________________________________________________________________

5th most common cancer in the UK

Melanoma, the most dangerous type of skin cancer, is the fifth most common cancer in the UK, accounting for around 4% of all new cancer cases, according to the NHS.

Analysis by Cancer Research UK found cases had risen by a third between 2009 and 2019.

“Skin cancer can have a devastating impact, and we know that cancer vaccines have the potential to revolutionise cancer care for patients in this country and across the world – and to save more lives,” said NHS National Cancer Director Peter Johnson.

The new DNA vaccine is not personalized to each patient’s tumor but aims to improve the immune system’s recognition of cancer cells to boost the response to immunotherapy.

“This will accelerate the discovery of transformative treatments and improve services for patients, driving growth across the country while making sure as many people as possible can benefit from cutting-edge treatments,” Starmer said.

-Source: AA

__________________________________________________________________________

FOLLOW INDEPENDENT PRESS:

WhatsApp CHANNEL
https://whatsapp.com/channel/0029VaAtNxX8fewmiFmN7N22